{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:13:25Z","timestamp":1787026405098,"version":"build-2736575974"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Gallbladder cancer is characterized by a dismal prognosis, with a limited number of biological markers currently identified for the carcinogenesis, progression and prognosis of gallbladder cancers (GBCs). The discovery of efficacious biomarkers is crucial for enhancing the prognosis of gallbladder cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Analysis of RNAseq datasets from gallbladder cancer allowed the identification of differential genes between gallbladder cancer and adjacent tissues. Subsequent application of Mendelian randomization extracted target gene known to promote gallbladder cancer from these differentially expressed genes. Immunohistochemistry was then conducted to evaluate the expression of these target gene in a cohort of 215 patients with gallbladder cancer, utilizing follow-up information to determine their prognostic value. Moreover, single-cell sequencing data of gallbladder cancer elucidated the role of target genes within the immune microenvironment of this cancer type. The Genomics of Therapeutics Response Portal (CTRP) database enabled the assessment of the impact of target genes on the IC50 of chemotherapy drugs. Lastly, network pharmacology and analytical methodologies were employed to investigate the effects of traditional Chinese medicine active ingredients targeting these specific genes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>ASPH expression is notably elevated in gallbladder cancer tissues, correlating with an unfavorable prognosis for patients afflicted with this disease. Results from Mendelian randomization studies suggest that heightened ASPH levels play a significant role in the development of gallbladder polyps and stones, which are established clinical risk factors in gallbladder cancer. Analysis of clinical samples demonstrates a positive association between ASPH expression and indicators of poor differentiation, increased tumor size, advanced TNM stage, lymph node metastasis, and invasion. The single-cell immune microenvironment reveals that ASPH not only enhances the expression of immune checkpoints, namely PDL1 and PVR, in the gallbladder cancer epithelium, resulting in immune evasion, but also triggers epithelial-mesenchymal transition and migration, promoting metastasis. Furthermore, ASPH contributes to heightened tumor drug metabolism, hence raising the IC50 values for gemcitabine and paclitaxel. Utilizing network pharmacology and molecular docking techniques, this study pinpointed six bioactive compounds derived from traditional Chinese medicine with a targeted effect on the ASPH protein, comprising Sebacic acid, Suberic acid, Azelaic acid, Dimelic acid, Succinic acid, and D-Asparaginsaeure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ASPH plays a role in promoting the development of gallbladder cancer and resistance to chemotherapeutic agents, rendering it a promising target for therapeutic interventions. Active therapeutic compounds targeted on ASPH can be identified among the active ingredients present in traditional Chinese medicine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1452345","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:16:36Z","timestamp":1741133796000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Aspartate beta-hydroxylase is a prognostic factor in gallbladder cancer with the function of promoting tumorigenesis and chemoresistance"],"prefix":"10.3389","volume":"16","author":[{"given":"Luo","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Yunpeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Yongxiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.gtc.2010.02.006","article-title":"Management of gallbladder cancer","volume":"39","author":"Jayaraman","year":"2010","journal-title":"Gastroenterol Clinics North America"},{"key":"B2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA: Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-006-0075-x","article-title":"Diagnosis and surgical management of gallbladder cancer: a review","volume":"11","author":"Reid","year":"2007","journal-title":"J gastrointestinal Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2004.03.011","article-title":"Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer","volume":"11","author":"Hawkins","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920601)69:11<2647::AID-CNCR2820691105>3.0.CO;2-0","article-title":"Relationship between gallbladder carcinoma and the segmental type of adenomyomatosis of the gallbladder","volume":"69","author":"Ootani","year":"1992","journal-title":"Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4174\/jkss.2012.82.1.54","article-title":"Primary carcinosarcoma of the gallbladder","volume":"82","author":"Park","year":"2012","journal-title":"J Korean Surg Soc"},{"key":"B7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/dc.21821","article-title":"MTDH and EphA7 are markers for metastasis and poor prognosis of gallbladder adenocarcinoma","volume":"41","author":"Liu","year":"2013","journal-title":"Diagn cytopathology"},{"key":"B8","article-title":"ECM dependent and integrin mediated tumor cell migration of human glioma and melanoma cell lines under serum-free conditions","volume":"16","author":"Goldbrunner","year":"1996","journal-title":"Anticancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118918","article-title":"Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma","volume":"98","author":"Lavaissiere","year":"1996","journal-title":"J Clin Invest"},{"key":"B10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3109\/15419069509081276","article-title":"Adhesion of human glioma cell lines to fibronectin, laminin, vitronectin and collagen I is modulated by gangliosides in vitro","volume":"3","author":"Merzak","year":"1995","journal-title":"Cell adhesion communication"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2006.09.012","article-title":"Teneurins: transmembrane proteins with fundamental roles in development","volume":"39","author":"Tucker","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"B12","article-title":"Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness","volume":"44","author":"de la Monte","year":"2006","journal-title":"J Hepatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)00052-7","article-title":"Antisense oligodeoxynucleotides directed against aspartyl (asparaginyl) beta-hydroxylase suppress migration of cholangiocarcinoma cells","volume":"38","author":"Maeda","year":"2003","journal-title":"J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23650","article-title":"Overexpression of aspartyl-(asparaginyl)-beta-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome","volume":"52","author":"Wang","year":"2010","journal-title":"Hepatol (Baltimore Md)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2840","article-title":"Aspartate \u03b2-Hydroxylase expression promotes a Malignant pancreatic cellular phenotype","volume":"6","author":"Dong","year":"2015","journal-title":"Oncotarget"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3858\/emm.2009.41.2.013","article-title":"Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells","volume":"41","author":"Yoo","year":"2009","journal-title":"Exp Mol Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.98.4.1619","article-title":"A TSG101\/MDM2 regulatory loop modulates MDM2 degradation and MDM2\/p53 feedback control","volume":"98","author":"Li","year":"2001","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B18","article-title":"Adenosquamous carcinoma of the gallbladder","volume":"49","author":"Kondo","year":"2002","journal-title":"Hepato-gastroenterology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2011.11.033","article-title":"Aldehyde dehydrogenases and cell proliferation","volume":"52","author":"Muzio","year":"2012","journal-title":"Free Radical Biol Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2006.06.005","article-title":"Role of aspartyl-(asparaginyl) beta-hydroxylase in placental implantation: Relevance to early pregnancy loss","volume":"38","author":"Gundogan","year":"2007","journal-title":"Hum Pathol"},{"key":"B21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/0929866530666221019162943","article-title":"FN1 promotes thyroid carcinoma cell proliferation and metastasis by activating the NF-Kb pathway","volume":"30","author":"Chen","year":"2023","journal-title":"Protein Pept Lett"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168642","article-title":"Visfatin promotes the metastatic potential of chondrosarcoma cells by stimulating AP-1-Dependent MMP-2 production in the MAPK pathway","volume":"22","author":"Hung","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-023-00704-0","article-title":"SPP1(+) TAM subpopulations in tumor microenvironment promote intravasation and metastasis of head and neck squamous cell carcinoma","volume":"31","author":"Wu","year":"2024","journal-title":"Cancer Gene Ther"},{"key":"B24","doi-asserted-by":"publisher","first-page":"108708","DOI":"10.1016\/j.biopha.2019.108708","article-title":"Collagen facilitates the colorectal cancer stemness and metastasis through an integrin\/PI3K\/AKT\/Snail signaling pathway","volume":"114","author":"Wu","year":"2019","journal-title":"Biomedicine pharmacotherapy = Biomedecine pharmacotherapie"},{"key":"B25","article-title":"Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with Malignant transformation","volume":"60","author":"Ince","year":"2000","journal-title":"Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21272","article-title":"Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms","volume":"44","author":"Cantarini","year":"2006","journal-title":"Hepatol (Baltimore Md)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/hep.24629","article-title":"Immunization with aspartate-\u03b2-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma","volume":"55","author":"Noda","year":"2012","journal-title":"Hepatol (Baltimore Md)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00431-4","article-title":"Programmed death ligand 1 signals in cancer cells","volume":"22","author":"Kornepati","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.ccell.2021.07.007","article-title":"The CD155\/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer","volume":"39","author":"Freed-Pastor","year":"2021","journal-title":"Cancer Cell"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70388-0","article-title":"Modulation of cytochrome P450 activity: implications for cancer therapy","volume":"6","author":"Scripture","year":"2005","journal-title":"Lancet Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.0270","article-title":"Gemcitabine, cisplatin, and nab-Paclitaxel for the treatment of advanced biliary tract cancers: A phase 2 clinical trial","volume":"5","author":"Shroff","year":"2019","journal-title":"JAMA Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt540","article-title":"Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials","volume":"25","author":"Valle","year":"2014","journal-title":"Ann oncology: Off J Eur Soc Med Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184331","article-title":"Molecular docking: shifting paradigms in drug discovery","volume":"20","author":"Pinzi","year":"2019","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1452345\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:16:43Z","timestamp":1741133803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1452345\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":35,"alternative-id":["10.3389\/fendo.2025.1452345"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1452345","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"article-number":"1452345"}}